JPRN-UMIN000023906已完成2 期
Arterial infusion chemotherapy concurrent with radiation therapy followed by systemic gemcitabine and cisplatin therapy for unresectable biliary tract cancer patients; A phase2 study - A phase2 study of AI+RT followed by systemic GEM+CDDP therapy for unresectable biliary tract cancer patients
Asahikwa Medical University0 个研究点目标入组 20 人开始时间: 2016年9月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Resectable biliary tract cancer
研究者
相似试验
已完成
2 期
Transcatheter arterial infusion chemotherapy using cisplatin powder and iodized-oil for advanced hepatocellular carcinoma: a phase 2 studyHCCJPRN-UMIN000005495Japan Society of Transcatheter Hepatic Arterial Embolization Clinical Reserch Group35
已完成
不适用
Transcatheter arterial infusion chemotherapy using miriplatin in patients with advanced hepatocellular carcinoma: Prospective randomized study, Lip-TAI vs. Lip+DSM-TAIhepatocellular carcinomaJPRN-UMIN000004526Department of Gastroenterology and Hepatology, Yamaguchi Univercity Graduate School of Medicine100
尚未招募
不适用
Effect of arterial infusion chemotherapy and chemoradiation therapy for locally advanced unresectable pancreatic cancer. - Phase II clinical studypancreatic cancerJPRN-UMIN000012249Department of genaral and gastroenterological surgery, Osaka medical college34
进行中（未招募）
不适用
Treatment With Chemotherapy and Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)Diffuse Large B Cell Lymphoma and HIV InfectionEUCTR2006-003750-23-ESFundación PETHEMA
进行中（未招募）
不适用
Combined systemic an intrathecal chemotherapy with succeeding high dosis chemotherapy and autologous stem cell transplantation of patients with CNS relapses of agressive lymphomas. - NHL-ZNS-RezidivThe aim of the study is the prospective verification of effectiveness and compatibility of a systemic therapy with CNS passable cytostatics (high-dose Methotrexat and Ifosfamide, and high-dose Cytarabine and Thiothepa) combined with an intrathecal Depocyte therapy, followed by a High-dose dose chemotherapy with Carmustine, Thiothepa and Etoposid and an autologous stem cell transplantation.EUCTR2006-006516-30-DECharité-Universitätsmedizin Berlin